The Significance of One-Station N2 Disease in the Prognosis of Patients With Nonsmall-Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 86, Issue 5, 2008, Pages 1626-1630

  Misthos, Panagiotis ^a   Sepsas, Evangelos ^b   Kokotsakis, John ^a   Skottis, Ion ^b   Lioulias, Achilleas ^a  

^a SISMANOGLIO HOSPITAL   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, BRONCHOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 53849120572     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.07.076     Document Type: Article

References (33)

1. Hata E., Hayakawa K., Miyamoto H., and Hayashida R. Rationale for extended lymphadenectomy for lung cancer. Theor Surg 5 (1990) 19-25
2. Watanabe Y., Shimizu J., Tsubota M., and Iwa T. Mediastinal spread of metastatic lymph nodes in bronchogenic carcinoma. Chest 97 (1990) 1059-1065
3. Libshitz H.I., Mckenna R.J., and Mountain C.F. Patterns of mediastinal metastases in bronchogenic carcinoma. Chest 90 (1986) 229-232
4. Nohl H.C. The spread of carcinoma of the bronchus (1962), Lloyd-Luke, London 17-44
5. Cerfolio R.J., and Bryant A.S. Distribution and likelihood of lymph node metastasis based on the lobar location of non-small cell lung cancer. Ann Thorac Surg 81 (2006) 1969-1973
6. Kotoulas C.S., Foroulis C.N., Kostikas K., et al. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location. Lung Cancer 44 (2004) 183-191
7. Mountain C.F. Revision of the international system for staging lung cancer. Chest 111 (1997) 1710-1717
8. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
9. Takizawa T., Terashima M., Koike T., Akamatsu H., Kurita Y., and Yokoyama A. Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg 113 (1997) 248-252
10. Inoue M., Sawabata N., Takeda S., et al. Results of surgical intervention for p-stage III(N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in upper lobe. J Thorac Cardiovasc Surg 127 (2004) 1100-1106
11. Riquet M., Hidden G., and Debesse B. Direct lymphatic drainage of lung segments to the mediastinal nodes. J Thorac Cardiovasc Surg 97 (1989) 623-632
12. Yoshino I., Yokohama H., Yano T., et al. Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg 62 (1996) 1021-1025
13. Pearson F.G., De Larue N.C., Ilves R., Todd T.R., and Cooper J.D. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 83 (1982) 1-11
14. Naruke T., Goya T., Tsuchiya R., and Suemasu K. The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg 46 (1988) 603-610
15. Goldstraw P., Mannam G.C., Kaplan D.K., and Michail P. Surgical management of non-small cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 107 (1994) 19-28
16. Roth J.A., Fossella F., Komaki R., et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 86 (1994) 673-680
17. Rossell R., Gomez-Codina J., Camps C., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330 (1994) 153-158
18. Daly B.D., Mueller J.D., Faling L.J., et al. N2 lung cancer: outcome in patients with false negative computed tomographic scans of the chest. J Thorac Cardiovasc Surg 105 (1993) 904-1
19. Cybulsky I.J., Lanza L.A., Ryan M.B., et al. Prognostic significance of computed tomography in resected N2 lung cancer. Ann Thorac Surg 54 (1992) 533-537
20. Vansteenkiste J.F., De Leyn P.R., Deneffe G.J., et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group. Ann Thorac Surg 63 (1997) 1441-1450
21. Nakanishi R., Osaki T., Nakanishi K., et al. Treatment strategy for patients with surgically discovered N2 stage IIIA nonsmall-cell lung cancer. Ann Thorac Surg 64 (1997) 342-348
22. Andre F., Grunenwald D., Pignon J.P., Dujon A., Pujol J.L., and Brichon P.Y. Survival of patients with resected N2 non-small cell lung cancer: evidence of subclassification and implications. J Clin Oncol 18 (2000) 2981-2989
23. Suzuki K., Nagai K., Yoshida J., Nishimura M., Takahashi K., and Nishiwaki Y. The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg 118 (1999) 145-153
24. Misthos P., Sepsas E., Athanassiadi K., Kakaris S., and Skottis I. Skip metastases: analysis of their clinical significance and prognosis in the IIIA/N2 NSCLC group. Eur J Cardiothorac Surg 25 (2004) 502-508
25. Detterbeck F. What to do with "surprise" N2?. Intraoperative management of patients with non-small cell lung cancer. J Thorac Oncol 3 (2008) 289-302
26. Yoshimasu T., Miyoshi S., Oura S., Hirai I., Kokawa Y., and Okamura Y. Limited mediastinal lymph node dissection for non-small cell lung cancer according to intraoperative histologic examinations. J Thorac Cardiovasc Surg 130 (2005) 433-437
27. Sakao Y., Miyamoto H., Oh S., Takahashi N., and Sakuraba M. Clinicopathological factors associated with unexpected N3 in patients with mediastinal lymph node involvement. J Thorac Oncol 2 (2007) 1107-1111
28. Gawrychowski J., Gabriel A., and Lackowska B. Heterogeneity of stage IIIA non-small cell lung cancers (NSCLC) and evaluation of late results of surgical treatment. Eur J Surg Oncol 29 (2003) 178-184
29. Martini N., and Fleshinger B.J. The role of surgery in N2 lung cancer. Surg Clin North Am 67 (1987) 1037-1049
30. Regnard J.F., Magdeleinat P., Azoulay D., et al. Results of resection for bronchogenic carcinoma with mediastinal lymph node metastases in selected patients. Eur J Cardiothorac Surg 5 (1991) 583-587
31. Watanabe Y., Shimizu J., Oda M., et al. Aggressive surgical intervention in N2 nonsmall-cell cancer of the lung. Ann Thorac Surg 51 (1991) 253-261
32. Sagawa M., Sakurada A., Fujimura S., et al. Five-year survivals with resected pN2 non-small cell lung carcinoma. Cancer 85 (1999) 864-868
33. Watanabe S., Suzuki K., and Asamura H. Superior and basal segment lung cancers in the lower lobe have different lymph node metastatic pathways and prognosis. Ann Thorac Surg 85 (2008) 1026-1031